UNITED STATES

SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549

SCHEDULE 13G/A

Under the Securities Exchange Act of 1934

(Amendment No. 1)*

EAGLE PHARMACEUTICALS, INC.

(Name of Issuer)

Common stock, $0.001 par value per share

(Title of Class of Securities)

269796108

(CUSIP Number)

October 30, 2024

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

o Rule 13d-1(b)

x Rule 13d-1(c)

o Rule 13d-1(d)

*The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

CUSIP No. 269796108

SCHEDULE 13G/A

Page 2 of 10 Pages


1	NAME OF REPORTING PERSONS Union Square Park Partners, LP
2	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) o (b) o
3	SEC USE ONLY
4	CITIZENSHIP OR PLACE OF ORGANIZATION Delaware, United States
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH		5	SOLE VOTING POWER 0
		6	SHARED VOTING POWER 1,321,385
		7	SOLE DISPOSITIVE POWER 0
		8	SHARED DISPOSITIVE POWER 1,321,385

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

1,321,385

CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

10.17%

TYPE OF REPORTING PERSON

CUSIP No. 269796108

SCHEDULE 13G/A

Page 3 of 10 Pages


1	NAME OF REPORTING PERSONS Union Square Park Capital Management, LLC
2	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) o (b) o
3	SEC USE ONLY
4	CITIZENSHIP OR PLACE OF ORGANIZATION Delaware, United States
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH		5	SOLE VOTING POWER 0
		6	SHARED VOTING POWER 1,321,385
		7	SOLE DISPOSITIVE POWER 0
		8	SHARED DISPOSITIVE POWER 1,321,385

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

1,321,385

CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

10.17%

TYPE OF REPORTING PERSON

CUSIP No. 269796108

SCHEDULE 13G/A

Page 4 of 10 Pages


1	NAME OF REPORTING PERSONS Union Square Park GP, LLC
2	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) o (b) o
3	SEC USE ONLY
4	CITIZENSHIP OR PLACE OF ORGANIZATION Delaware, United States
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH		5	SOLE VOTING POWER 0
		6	SHARED VOTING POWER 1,321,385
		7	SOLE DISPOSITIVE POWER 0
		8	SHARED DISPOSITIVE POWER 1,321,385

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

1,321,385

CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

10.17%

TYPE OF REPORTING PERSON

CUSIP No. 269796108

SCHEDULE 13G/A

Page 5 of 10 Pages


1	NAME OF REPORTING PERSONS Leon Zaltzman
2	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) o (b) o
3	SEC USE ONLY
4	CITIZENSHIP OR PLACE OF ORGANIZATION United States
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH		5	SOLE VOTING POWER 0
		6	SHARED VOTING POWER 1,321,385
		7	SOLE DISPOSITIVE POWER 0
		8	SHARED DISPOSITIVE POWER 1,321,385

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

1,321,385

CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

10.17%

TYPE OF REPORTING PERSON

CUSIP No. 269796108

SCHEDULE 13G/A

Page 6 of 10 Pages

Item 1.

(a) Name of Issuer

EAGLE PHARMACEUTICALS, INC.

Item 1.

(b) Address of Issuer’s Principal Executive Offices

50 Tice Boulevard, Suite 315

Woodcliff Lake, NJ 07677

Item 2.

(a) Names of Persons Filing:

Union Square Park Partners, LP

Union Square Park Capital Management, LLC

Union Square Park GP, LLC

Leon Zaltzman

(b) Address of Principal Business Office:

Union Square Park Partners, LP, 1120 Avenue of the Americas, Suite 1502, New York, NY, 10036

Union Square Park Capital Management, LLC,1120 Avenue of the Americas, Suite 1502, New York, NY, 10036

Union Square Park GP, LLC, 1120 Avenue of the Americas, Suite 1502, New York, NY, 10036

Leon Zaltzman, 1120 Avenue of the Americas, Suite 1502, New York, NY, 10036

(c) Citizenship:

Please refer to Item 4 on each cover sheet for each filing person.

Item 2.

(d) Title of Class of Securities

Common stock, par value $0.0001 per share

Item 2.

(e) CUSIP No.:

269796108

CUSIP No. 269796108

SCHEDULE 13G/A

Page 7 of 10 Pages


Item 3. If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:

(a)	¨	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);

(b)	¨	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);

(c)	¨	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);

(d)	¨	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);

(e)	o	An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E);

(f)	¨	An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F);

(g)	¨	A parent holding company or control person in accordance with §240.13d-1(b)(1)(ii)(G);

(h)	¨	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);

(i)	¨	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);

(j)	¨	A non-U.S. institution in accordance with §240.13d-1(b)(1)(ii)(J);

(k)	¨	A group, in accordance with §240.13d-1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with §240.13d-1(b)(1)(ii)(J), please specify the type of institution:

Not applicable

CUSIP No. 269796108

SCHEDULE 13G/A

Page 8 of 10 Pages

Item 4. Ownership

(a) Amount beneficially owned: 1,321,385

(b) Percent of class: 10.17%

(i) Sole power to vote or to direct the vote: 0

(ii) Shared power to vote or to direct the vote: 1,321,385

(iii) Sole power to dispose or to direct the disposition of: 0

(iv) Shared power to dispose or to direct the disposition of: 1,321,385

Item 5. Ownership of Five Percent or Less of a Class

If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following [ ].

Item 6. Ownership of More Than Five Percent on Behalf of Another Person

Not Applicable.

Item 7. Identification and Classification of the Subsidiary which Acquired the Security Being Reported on by the Parent Holding Company or Control Person

Not Applicable.

Item 8. Identification and Classification of Members of the Group

Not Applicable.

Item 9. Notice of Dissolution of Group

Not Applicable.

Item 10. Certification

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

CUSIP No. 269796108

SCHEDULE 13G/A

Page 9 of 10 Pages

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Dated: October 31, 2024

Union Square Park Partners, LP

By: /s/ Leon Zaltzman

Name: Leon Zaltzman

Title: Managing Member of the General Partner

	Union Square Park Capital Management, LLC

	By:	/s/ Leon Zaltzman
		Name: Leon Zaltzman Title: Managing Member


	Union Square Park GP, LLC

	By:	/s/ Leon Zaltzman
		Name: Leon Zaltzman Title: Managing Member

	Leon Zaltzman

		/s/ Leon Zaltzman
		Name: Leon Zaltzman

CUSIP No. 269796108

SCHEDULE 13G/A

Page 10 of 10 Pages

Exhibit I

JOINT FILING STATEMENT

PURSUANT TO RULE 13d-1(k)

The undersigned acknowledge and agree that the foregoing statement on SCHEDULE 13G/A, is filed on behalf of each of the undersigned and that all subsequent amendments to this statement on SCHEDULE 13G/A, shall be filed on behalf of each of the undersigned without the necessity of filing additional joint acquisition statements. The undersigned acknowledge that each shall be responsible for the timely filing of such amendments, and for the completeness and accuracy of the information concerning him or it contained therein, but shall not be responsible for the completeness and accuracy of the information concerning the others, except to the extent that he or it knows or has reason to believe that such information is inaccurate.

Dated: October 31, 2024

Union Square Park Partners, LP

By: /s/ Leon Zaltzman

Name: Leon Zaltzman

Title: Managing Member of the General Partner

	Union Square Park Capital Management, LLC

	By:	/s/ Leon Zaltzman
		Name: Leon Zaltzman Title: Managing Member


	Union Square Park GP, LLC

	By:	/s/ Leon Zaltzman
		Name: Leon Zaltzman Title: Managing Member

	Leon Zaltzman

		/s/ Leon Zaltzman
		Name: Leon Zaltzman

EAGLE PHARMACEUTICALS, INC. SC 13G/A